Incyte market cap
WebMar 23, 2024 · Incyte is a global biopharmaceutical company founded on the premise that investment in strong science and the relentless pursuit of R&D excellence can translate … WebApr 12, 2024 · The firm has a market cap of $16.62 billion, a P/E ratio of 49.03, a PEG ratio of 3.28 and a beta of 0.73. The firm has a 50-day moving average price of $76.11 and a two-hundred day moving average price of $76.92. Incyte has a 52-week low of $65.07 and a 52-week high of $86.29. Gilead Sciences: Now is Not the Time to Get Sticker Shock
Incyte market cap
Did you know?
WebIncyte Market Cap Incyte is currently regarded as number one stock in market capitalization category among related companies. Market capitalization of Health Care industry is currently estimated at about 24.96 Billion. Incyte totals roughly 17.91 Billion in market capitalization claiming about 72% of equities under Health Care industry. WebApr 6, 2024 · Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for hematology/oncology, and inflammation and autoimmunity areas in...
WebApr 10, 2024 · INCY Complete Incyte Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. WebApr 11, 2024 · Incyte Co. has a 1-year low of $65.07 and a 1-year high of $86.29. The company has a market cap of $16.48 billion, a price-to-earnings ratio of 48.64, a price-to-earnings-growth ratio of 3.28 and ...
WebApr 10, 2024 · Market Cap $16.45B Shares Outstanding 222.97M Public Float 220.79M Beta 0.68 Rev. per Employee $1.461M P/E Ratio 49.62 EPS $1.52 Yield N/A Dividend N/A Ex-Dividend Date N/A Short Interest 6.53M... Web24 rows · As of April 2024 Incyte has a market cap of $16.83 Billion. This makes Incyte the world's 999th most valuable company by market cap according to our data. The market …
WebMarket Cap Historical daily share price chart and data for Incyte since 1993 adjusted for splits. The latest closing stock price for Incyte as of April 06, 2024 is 75.51. The all-time high Incyte stock closing price was 152.66 on March 15, 2024. The Incyte 52-week high stock price is 86.29, which is 14.3% above the current share price.
WebArtiva Biotherapeutics, Inc. (ARTV) Stock Price, Quote & News - Stock Analysis Artiva Biotherapeutics, Inc. ( ARTV) Artiva Biotherapeutics was planning to go public, but the IPO has been withdrawn. Stock Price: Pending IPO price not available yet Overview Statistics Profile Chart not available yet Data will show when the stock starts trading. how can we achieve market equilibriumWebSep 18, 2024 · As of the close on September 17, at $90.35 per share, Incyte had a market capitalization approaching $20 billion. The 52-week low was $62.48, versus the 52-week high of $110.37. The most... how can we achieve our dreamsWebFeb 23, 2000 · NEW YORK (CNNfn) - Bullish on the outlook for the already high-flying genomics segment of the biotech industry, a Wall Street analyst raised his 12-month price target Wednesday on genetic... how can we achieve sdg 17WebApr 12, 2024 · The company has a market cap of $16.54 billion, a price-to-earnings ratio of 48.80, a PEG ratio of 3.28 and a beta of 0.73. The company has a current ratio of 3.54, a quick ratio of 3.50 and a ... how can we achieve peace through educationWebApr 11, 2024 · According to analysts' consensus price target of $85.43, Incyte has a forecasted upside of 15.2% from its current price of $74.17. Amount of Analyst Coverage … how many people live in newcastle nswWebApr 15, 2024 · Incyte Co. has a twelve month low of $65.07 and a twelve month high of $86.29. The stock has a market cap of $16.66 billion, a price-to-earnings ratio of 49.56, a P/E/G ratio of 3.22 and a beta of 0.73. The company has a quick ratio of 3.50, a current ratio of 3.54 and a debt-to-equity ratio of 0.01. how can we achieve polymorphism in javaWebMar 11, 2024 · Incyte's ruxolitinib, a type of non-steroidal anti-inflammatory medication called a JAK inhibitor, already makes up a major chunk of earnings, representing $2.22 … how can we acquire immunity class 9